Abstract | BACKGROUND: METHODS: Employing RT-PCR and Western blot, we examined the role of Sp1 in ADAM17 transcription/expression under normoxic and hypoxic conditions, and whether it binds to the ADAM17 GC-rich promoter region using a chromatin immunoprecipitation assay. Additionally, we tested the effect of Sp1 suppression in tumor cell invasion and migration, using Matrigel basement membrane invasion chambers, a scratch wound-healing assay, and small interfering RNA. RESULTS: Here, we found that Sp1 binds to the ADAM17 promoter, and that Sp1 regulates ADAM17 expression under hypoxia. Furthermore, suppression of Sp1 decreases invasiveness and migration in U87 tumor cells. CONCLUSION:
|
Authors | Alexandra Szalad, Mark Katakowski, Xuguang Zheng, Feng Jiang, Michael Chopp |
Journal | Journal of experimental & clinical cancer research : CR
(J Exp Clin Cancer Res)
Vol. 28
Pg. 129
(Sep 22 2009)
ISSN: 1756-9966 [Electronic] England |
PMID | 19772640
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Immunoglobulins
- SP1 antigen
- ADAM Proteins
- ADAM17 Protein
- ADAM17 protein, human
|
Topics |
- ADAM Proteins
(genetics, metabolism)
- ADAM17 Protein
- Blotting, Western
- Brain Neoplasms
(genetics, metabolism, pathology)
- Cell Hypoxia
(physiology)
- Cell Movement
(genetics)
- Gene Expression Regulation, Neoplastic
- Glioma
(genetics, metabolism, pathology)
- Humans
- Immunoglobulins
(genetics, metabolism)
- Immunoprecipitation
- Neoplasm Invasiveness
(genetics)
- Promoter Regions, Genetic
- Reverse Transcriptase Polymerase Chain Reaction
|